Convergent Dental Raises $40M in Series C Funding

Convergent Dental, a Needham, MA-based developer of a laser to enable anesthesia-free, pain-free dentistry, raised $40M in Series C funding round.

The round was led by Arboretum Ventures, with participation from existing investors, including Long River Ventures and the Gund Foundation.

The company intends to use the funds to expand its product portfolio and increase investment in market development.

Led by Michael Cataldo, Chief Executive Officer, Solea provides a all-tissue laser for dentistry. This technology enables virtually any cavity to be treated without anesthesia and soft tissue (gum) surgeries to be completed with little to no anesthesia, bleeding or sutures. In addition, the company recently launched Solea Sleep, a painless, non-surgical treatment for snoring that works by tightening tissue in the soft palate in a simple 5-minute treatment.